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Epigenetic gene silencing by aberrant DNA methylation leads to loss of key cellular pathways in tumorigenesis. DNA 
methylation-mediated silenced genes in pancreatic cancer were searched for using the methyl-CpG targeted 
transcriptional activation (MeTA) method, and LHX6 (LIM homeobox 6), a transcription factor involved in 
embryogenesis as well as CNS and craniofacial development, was selected as a strong candidate gene. LHX6 was 
downregulated in most of the pancreatic cancer cell lines (83%, 10/12), mainly through promoter hypermethylation and 
histone deacetylation. Furthermore, LHX6 was methylated in primary pancreatic cancer specimens (57%, 16/28) in a 
tumor-specific manner. In order to assess the biological significance of LHX6 in pancreatic tumorigenesis, I first 
performed colony formation assay and found that LHX6 re-expression inhibited colony formation in LHX6 
low-expressing pancreatic cancer cell lines, PK-1 and PK-9. Similarly, inducible expression of LHX6 inhibited cell 
proliferation and migration in PK-1 and PK-9 cells. In contrast, knockdown of LHX6 accelerated cell proliferation in 
LHX6 high-expressing pancreatic cancer cell lines, PCI-35 and MIA PaCa-2. Although LHX6 has been reported to be 
involved in the Wnt/ -catenin pathway in breast and lung cancers and my microarray analysis indicated that LHX6 
induction in both PK-1 and PK-9 cells upregulated DKK4, which functions as a Wnt antagonist, LHX6 induction did not 
affect any CTNNB1 protein expressions. On the other hand, I also found that TFPI2, Tissue factor pathway inhibitor-2, 
was upregulated in accordance with LHX6 induction in both PK-1 and PK-9 cells. TFPI2 may function as a tumor 
suppressor in a LHX6-dependent manner, which differs from a well-known promoter hypermethylation. My present 
results suggest that epigenetic inactivation of LHX6 plays an important role in pancreatic tumorigenesis by promoting 
cell proliferation through the regulation of several downstream genes. 
 
